Reuth Medical Center and Cupron Sign Agreement to Supply Textiles Following Successful Clinical Trial Cupron Inc., and Reuth Medical Center in Tel Aviv, Israel, announced that the hospital will be updating all of its patient-related hospital textiles to Cupron’s copper-embedded products later this summer. It will be the world’s first hospital to fully deploy copper-embedded textiles.
Cupron and NASA are partnering to test the effectiveness of antimicrobial textiles in a simulated space environment over a 120-day period as part of NASA’s HI-SEAS program. Cupron will be supplying a head-to-toe range of Cupron-enhanced garments to help determine if antimicrobial textiles can reduce bacterial cross-contamination and limit the amount of space needed to
Company’s fibers demonstrate ability to kill 99.99% of athlete’s foot cause in 12 hours Cupron, creator of a copper-based antimicrobial technology, announced today that its pioneering technology has received the U.S. Environmental Protection Agency’s (EPA) approval to make a first-of-its-kind Public Health Claim. This is the third EPA Public Health Claim awarded to Cupron and